<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec><h3>Background</h3>
<p>Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure.</p>
</sec>
<sec><h3>Objectives</h3>
<p>To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19.</p>
</sec>
<sec><h3>Methods</h3>
<p>Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design.</p>
</sec>
<sec><h3>Result</h3>
<p>We included data from 150 (94 male) patients. Their mean age ± standard deviation was 68.56 ± 16.02 (range 21–97) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 ± 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease–heart failure, and diabetes mellitus.</p>
</sec>
<sec><h3>Conclusion</h3>
<p>COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present.</p>
</sec>
</abstract>

Background
Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure.

Objectives
To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19.

Methods
Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design.

Result
We included data from 150 (94 male) patients. Their mean age ± standard deviation was 68.56 ± 16.02 (range 21–97) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 ± 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease–heart failure, and diabetes mellitus.

Conclusion
COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present.

Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey

Department of Anaesthesiology and Reanimation

Asian Biomedicine

This work is licensed under the Creative Commons Attribution 4.0 International License.

Background
Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the...

Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey

Article Category: Original article

Data publikacji: 28 lut 2022

Zakres stron: 23 - 30

DOI: https://doi.org/10.2478/abm-2022-0004

Słowa kluczowe
COVID-19, neurological manifestations, SARS-CoV-2, seizure, Turkey

© 2022 Nuray Can Usta et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey

Article Category: Original article

Data publikacji: 28 lut 2022

Zakres stron: 23 - 30

DOI: https://doi.org/10.2478/abm-2022-0004

Słowa kluczoweCOVID-19, neurological manifestations, SARS-CoV-2, seizure, Turkey

© 2022 Nuray Can Usta et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Słowa kluczowe
COVID-19, neurological manifestations, SARS-CoV-2, seizure, Turkey